You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug RUGBY ALL DAY RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for RUGBY ALL DAY RELIEF

Last updated: February 27, 2026

What is the Role of Excipients in RUGBY ALL DAY RELIEF?

Excipients serve as inactive ingredients in formulations, providing stability, bioavailability, and user experience enhancements. For RUGBY ALL DAY RELIEF, excipients influence tablet stability, dissolution rate, and patient compliance. Common excipients include binders, fillers, disintegrants, lubricants, and coatings.

What Are the Key Excipients Used in RUGBY ALL DAY RELIEF?

Based on typical analgesic formulations, the following excipients are likely employed:

  • Binders: Crospovidone, microcrystalline cellulose (MCC)
  • Fillers/Fillers/Constructs: Lactose monohydrate, dibasic calcium phosphate
  • Disintegrants: Croscarmellose sodium, sodium starch glycolate
  • Lubricants: Magnesium stearate
  • Coatings: Hydroxypropyl methylcellulose (HPMC), shellac (if film-coated)

The selection balances drug stability, dissolution profile, manufacturing efficiency, and patient acceptance.

What Are the Intellectual Property Implications for Excipient Use?

While excipients are generally non-patented, specific formulations, combinations, or coating technologies can be protected as trade secrets or patents. Developing novel excipient blends or delivery systems enhances patentability and reduces generic competition.

How Can Excipient Optimization Present Commercial Opportunities?

  1. Enhanced Bioavailability: Formulations with optimized excipients can improve absorption, leading to better efficacy and patient outcomes.
  2. Extended-Release Formulations: Using specific excipients like water-insoluble polymers enables controlled release over 24 hours, appealing in the OTC segment.
  3. Taste-Masking Technologies: Incorporating flavoring agents and taste-masked coatings improves patient adherence, especially in pediatrics or sensitive populations.
  4. Manufacturing Efficiency: Excipient choices influence process complexity and cost, allowing differentiation via cost-effective or scalable formulations.
  5. Formulation Innovation: Novel excipients or delivery systems can create patentable products, enabling premium pricing.

What Are the Regulatory Considerations for Excipient Selection?

Regulatory bodies such as the FDA and EMA require excipients to meet safety standards. Use of novel excipients demands extensive toxicological data and approval processes. Standard excipients have well-established safety profiles, reducing regulatory risk.

What Market Dynamics Affect Excipient Strategy for RUGBY ALL DAY RELIEF?

Market competition is fixed on cost, efficacy, and patent protection. OTC analgesics like RUGBY ALL DAY RELIEF compete mainly on formulary differentiation and patent exclusivity. Innovations in excipient use that extend patent life or improve patient adherence generate commercial advantage.

What Are the Costs and Risks Associated with Excipient Changes?

Switching or optimizing excipients may increase development time and costs, with potential stability or bioavailability risks. Regulatory approvals may delay product launches. Nonetheless, differentiation and patentability often outweigh these risks.

What Are the Potential Innovation Pathways?

  • Developing novel controlled-release matrices
  • Incorporating taste-masking coatings for pediatric formulations
  • Using biodegradable or environmentally friendly excipients
  • Creating combination excipient systems for multi-therapy delivery

Conclusion

Strategic excipient selection can improve RUGBY ALL DAY RELIEF's efficacy, shelf-life, user experience, and marketability. Innovations, intellectual property protections, and regulatory compliance shape competitive advantage and commercial success.


Key Takeaways

  • Excipients impact formulation stability, bioavailability, and patient compliance.
  • Formulation innovation enables patent protection and market differentiation.
  • Cost-effective and scalable excipient choices influence manufacturing margins.
  • Regulatory approval depends on excipient safety profiles; novel excipients require extensive testing.
  • Market opportunities lie in controlled-release systems, taste-masking, and environmentally friendly excipients.

FAQs

1. How does excipient choice affect drug shelf-life?
Excipients influence chemical and physical stability, affecting moisture absorption, degradation pathways, and overall shelf life.

2. Can excipient modifications improve bioavailability?
Yes, excipients such as solubilizers or permeation enhancers facilitate drug absorption, improving bioavailability.

3. What are common challenges in excipient development?
Challenges include regulatory hurdles, potential drug-excipient interactions, and maintaining formulation stability.

4. How do excipients contribute to controlled-release formulations?
Using polymers or matrix systems, excipients control drug release rates, extending dosing intervals.

5. What is the significance of patenting excipient formulations?
Patent protection prevents generic competition, allowing premium pricing and market exclusivity.


References

  1. U.S. Food and Drug Administration. (2022). Inactive Ingredients Database. Retrieved from https://www.fda.gov
  2. Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (2009). Handbook of Pharmaceutical Excipients. Pharmaceutical Press.
  3. European Medicines Agency. (2018). Guideline on Excipients in the dossier for application for marketing authorization. EMA/CHMP/QWP/245684/2019.
  4. Ghosh, R. K. (2014). Pharmaceutical Technology: Excipients for Controlled Release. John Wiley & Sons.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.